Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia | Zendy

John W. Newcomer | Zendy; Dan Haupt | Zendy; Robert Fucetola | Zendy; Angela K. Melson | Zendy; Julia Schweiger | Zendy; Benjamin P. Cooper | Zendy; Gregg Selke | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia

Author(s) -

John W. Newcomer,

Dan Haupt,

Robert Fucetola,

Angela K. Melson,

Julia Schweiger,

Benjamin P. Cooper,

Gregg Selke

Publication year - 2002

Publication title -

archives of general psychiatry

Language(s) - English

Resource type - Journals

eISSN - 1538-3636

pISSN - 0003-990X

DOI - 10.1001/archpsyc.59.4.337

Subject(s) - clozapine , risperidone , medicine , olanzapine , antipsychotic , schizophrenia (object oriented programming) , endocrinology , diabetes mellitus , population , atypical antipsychotic , insulin , psychiatry , environmental health

Hyperglycemia and type 2 diabetes mellitus are more common in schizophrenia than in the general population. Glucoregulatory abnormalities have also been associated with the use of antipsychotic medications themselves. While antipsychotics may increase adiposity, which can decrease insulin sensitivity, disease- and medication-related differences in glucose regulation might also occur independent of differences in adiposity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research